These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study. Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834 [TBL] [Abstract][Full Text] [Related]
3. The value of post-chemotherapy surgery for residual disease in ovarian germ cell tumors. Naik R J Postgrad Med; 2006; 52(4):245-6. PubMed ID: 17191355 [No Abstract] [Full Text] [Related]
4. Bulletin board. Study suggests that following surgery, watchful waiting may be a safe option for girls with early-stage ovarian germ cell tumors. Future Oncol; 2010 Dec; 6(12):1825. PubMed ID: 21188885 [No Abstract] [Full Text] [Related]
5. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
7. Advanced germ cell malignancies of the ovary: should neo-adjuvant chemotherapy be the first line of treatment? Raveendran A; Gupta S; Bagga R; Saha SC; Gainder S; Dhaliwal LK; Patel F; Dey P; Nijhawan R J Obstet Gynaecol; 2010 Jan; 30(1):53-5. PubMed ID: 20121506 [TBL] [Abstract][Full Text] [Related]
8. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy. Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051 [TBL] [Abstract][Full Text] [Related]
9. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery]. Schröder W Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476 [TBL] [Abstract][Full Text] [Related]
15. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours. Gadducci A; Lanfredini N; Tana R Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194 [TBL] [Abstract][Full Text] [Related]
16. Outcome and prognostic factors in ovarian germ cell malignancies. Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426 [TBL] [Abstract][Full Text] [Related]
17. Ovarian germ cell tumors in children: a clinical study of 66 patients. De Backer A; Madern GC; Oosterhuis JW; Hakvoort-Cammel FG; Hazebroek FW Pediatr Blood Cancer; 2006 Apr; 46(4):459-64. PubMed ID: 16206211 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of ovarian germ cell tumors. Williams SD Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943 [TBL] [Abstract][Full Text] [Related]
19. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89]. Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of malignant ovarian germ cell tumors with relapse or failed in primary therapy]. Yang JX; Wang HB; Shen K; Huang HF; Pan LY; Wu M Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):273-6. PubMed ID: 19570465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]